reported full-year worldwide revenue of about $65 billion in 2025, with Keytruda (pembrolizumab)/Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) sales amounting to roughly $31.7 billion and continuing to be the companys dominant growth engine, alongside contributions from pulmonary arterial hypertension (PAH) drug Winrevair (sotatercept-csrk), pneumonia vaccine Capvaxive (neumococcal 21-valent conjugate vaccine) and animal health products
We anticipate being able to restore this protocol shortly after the committee meeting depending on the recommendation
The other interesting thing to note about the Eli Lilly license, David, which I thought was really clever, is it's a one year exclusive license where there are two conditions, and the conditions are a trade
Blood test markers to discuss with a clinician Marker A1c Why it matters Shows longer-term glucose control before and during metabolic-pathway stacking
There was also a reduction in total glutathione in the skeletal muscle of animals who exercised, compared to the sedentary control animals
glp-1(q224) is a temperature-sensitive and loss-of-function mutant like glp-1(bn18) mutants
